GlassScriptPhysician profile
Jonas R Te Paske
NPI 1780950949
$1,506.28
in general payments reported to CMS, 2019-2025
29 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $432 · 2020: $70.42 · 2021: $541 · 2022: $330 · 2023: $133.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $133.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $132.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $314.58 | 2019-2023 | Orilissa, Lo Loestrin Fe, Liletta |
| Bayer Healthcare Pharmaceuticals INC. | $110.44 | 2019-2022 | |
| Exeltis, USA INC. | $107.69 | 2021-2022 | |
| Coopersurgical, INC. | $98.60 | 2019-2022 | |
| Organon LLC | $84.68 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $83.96 | 2019-2021 | |
| Astellas Pharma US INC | $78.55 | 2019-2022 | |
| Pfizer INC. | $52.19 | 2019-2023 | |
| Roche Diagnostics Corporation | $43.90 | 2019-2021 | |
| Mylan Pharmaceuticals INC. | $41.85 | 2020-2022 | |
| Daiichi Sankyo INC. | $40.44 | 2023 | Injectafer |
| Aspira Women'S Health INC | $38.33 | 2022-2023 | Ova1 |
| Ethicon US, LLC | $38.20 | 2019-2022 | |
| Agile Therapeutics, INC. | $36.92 | 2021 | |
| Therapeuticsmd, INC. | $35.40 | 2019-2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $32.24 | 2022-2023 | Fluent Fluid Management System, Omni Hysteroscope |
| Avion Pharmaceuticals | $29.18 | 2021-2023 | Balcoltra |
| Aesculap, INC. | $26.44 | 2019 | |
| Lupin INC. | $26.30 | 2019 | |
| Mission Pharmacal Company | $26.25 | 2019 | |
| Allergan, INC. | $24.68 | 2019 | |
| Myovant Sciences INC. | $22.46 | 2022 | |
| Mayne Pharma Commercial LLC | $22.29 | 2022 | |
| Smith+Nephew, INC. | $17.74 | 2021 | |
| Medtronic, INC. | $17.58 | 2022 | |
| Avanos Medical | $16.66 | 2019 | |
| Ferring Pharmaceuticals INC. | $15.61 | 2019 | |
| Evofem Biosciences, INC. | $11.85 | 2021 | |
| Medtronic USA, INC. | $11.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonas Te Paske listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.